Conflicting evidence · gold-v0.1
SYNTHETIC RECORD - Example Delta Rheumatology - Medication History - 2026-06-05 Patient reference SYN-1056. TREXALL 15 MG PO WEEKLY - status: inactive - start 2026-04-06 - end 2026-06-01 - reason: nausea FOLIC ACID 1 MG PO DAILY - status: inactive - start 2026-04-06 FUROSEMIDE 20 MG PO DAILY - status: active
SYNTHETIC RECORD - Example Delta Rheumatology - Problem List Update - 2026-06-10 Patient reference SYN-1056. 68-year-old woman. - Seropositive rheumatoid arthritis, diagnosed 2014, followed at this practice since. - Methotrexate (MTX) 2026-04-06 to 2026-06-01, stopped for nausea that did not resolve with dose adjustment. - Mild chronic kidney disease, stage 2, monitored. - Plan: discuss next steps given the brief methotrexate trial; consider Immunara.
Decided by: default_review gate · auto_process 0.89
p_yes for yes/no questions; ticks are the thresholds a gate compares each one with.
all five decisions present and well-formed
patient.age=68, policy min_age=18
p_yes(material_contradiction)=0.140, review at >= 0.8
p_yes(documentation_complete)=0.950, request info below 0.6
missing_evidence=NONE (p=0.850), request info at >= 0.7
min(required p_yes)=0.000, auto at >= 0.89; p_yes(material_contradiction)=0.140, blocks at >= 0.2
case does not meet the autonomous-action bar
passed = the gate checked and did not fire; not reached = an earlier gate decided.
run_20260925T170857Z_b95be9 · q-v0.2 · immunara-v0.1 (v0.1)
auto_process 0.89, chosen on gen-v0.2-dev.
questions: q-v0.2 →